Related Experiment Video
Updated: Sep 20, 2026
Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest
Published on: August 6, 2015
Effects of calcium and magnesium pretreatment on hyperkalaemic cardiac arrest in rats
M W Hollmann1, D Strümper, V A Salmons
1University of Virginia, Department of Anesthesiology, Charlottesville, VA, USA.
Insights
Magnesium and calcium pretreatment did not prevent hyperkalemic cardiac arrest in rats. This study found no significant difference in survival times when these electrolytes were administered before potassium infusion.
Area of Science:
- Cardiovascular Physiology
- Electrolyte Balance
Background:
- Hyperkalemia poses a risk to cardiac function.
- Calcium administration can reverse hyperkalemia's effects, but its use as a pretreatment is unstudied.
- Magnesium has shown potential in cellular studies to mitigate potassium's cardiac impact.
Purpose of the Study:
- To investigate the efficacy of magnesium and calcium, alone or in combination, as pretreatment agents against hyperkalemic cardiac arrest.
- To determine if these electrolytes offer synergistic protection due to differing mechanisms of action.
Main Methods:
- Adult rats were pretreated with calcium chloride, magnesium sulfate, a combination, or saline.
- Potassium was infused until cardiovascular collapse.
- Key endpoints included time to first dysrhythmia, significant blood pressure drop, and collapse.
Main Results:
- Serum potassium levels rose similarly across all groups, reaching approximately 12.0 mmol/L at collapse.
- No significant differences in survival times were observed between the treatment and control groups.
- A trend suggested improved respiratory parameters in the magnesium-treated group.
Conclusions:
- Pretreatment with magnesium, calcium, or their combination did not alter the time to cardiovascular collapse in this rat model.
- These agents, at the tested doses and administration timing, are not beneficial in preventing hyperkalemic cardiac arrest.
Background And Objective:
Administration of calcium safely and effectively reverses many of the electrophysiological actions of hyperkalaemia, but it has not been studied for pretreatment. Based on cellular studies, magnesium also has been suggested to prevent the effects of potassium on the heart. As their mechanisms of action differ, a combination of these drugs might have a synergistic protective action. Both compounds are inexpensive and can be administered safely in modest doses. We investigated whether magnesium, calcium or their combination could protect against hyperkalaemic cardiac arrest.
Methods:
Twenty-four adult rats were anaesthetized with halothane and randomly pretreated with CaCl2 15 mg kg(-1), MgSO4 30 mg kg(-1), CaCl2 7.5 mg kg(-1) + MgSO4 15 mg kg(-1) or physiological saline. Potassium (0.01 mmol kg(-1) h(-1)) was infused. The times to the first dysrhythmia, mean arterial pressure decrease to <40% of baseline and cardiovascular collapse were measured.
Results:
Serum potassium concentrations increased to similar values in all groups (to 12.0 +/- 0.2 mmol L(-1) at the time of collapse). No differences in survival times were observed between groups. There was a trend for respiratory values to be better in the group receiving magnesium.
Conclusions:
Pretreatment with magnesium, calcium or a combination of both did not influence the time to cardiovascular collapse, and is therefore--at least in our model--not of any benefit in preventing hyperkalaemic cardiac arrest.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management